Larry L. Wood

Insider · President, CEO · PRCT

Larry L. Wood files insider transactions with the SEC as a president, ceo of PROCEPT BioRobotics (PRCT). We hold 1 disclosed purchase or sale filed since 12 November 2008, 1 of them in the last 90 days.

Files forPRCT
Disclosed buys and sells1 in all, 1 in the last 90 days
Last disclosure10 August 2026

Positions held

2 posts we hold — a term names its own dates; a run of filings only says when they filed

Filed 18 April 2024 — 7 August 2026President, CEO · PROCEPT BioRobotics (PRCT)13 Form 4 lines · source: SEC Form 4
Filed 10 November 2008 — 18 August 2025Global President TAVR & Surg · Edwards Lifesciences (EW)432 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

exercised options over 8,660 shares of Edwards Lifesciences (a derivative holding)SEC Form 413 November 2023Employee Stock Option (Right to Acquire) · traded 13 November 2023 · filed 13 November 2023
exercised options over 8,660 shares of Edwards Lifesciences (a derivative holding)SEC Form 413 October 2023Employee Stock Option (Right to Acquire) · traded 13 October 2023 · filed 13 October 2023
exercised options over 8,660 shares of Edwards LifesciencesSEC Form 413 October 2023Common Stock · traded 13 October 2023 · filed 13 October 2023
▼ sold on the open market 3,510 shares of Edwards LifesciencesSEC Form 413 October 2023Common Stock · traded 13 October 2023 · filed 13 October 2023
▼ sold on the open market 5,150 shares of Edwards LifesciencesSEC Form 413 October 2023Common Stock · traded 13 October 2023 · filed 13 October 2023
exercised options over 8,660 shares of Edwards Lifesciences (a derivative holding)SEC Form 414 September 2023Employee Stock Option (Right to Acquire) · traded 14 September 2023 · filed 14 September 2023
exercised options over 8,660 shares of Edwards LifesciencesSEC Form 414 September 2023Common Stock · traded 14 September 2023 · filed 14 September 2023
▼ sold on the open market 8,660 shares of Edwards LifesciencesSEC Form 414 September 2023Common Stock · traded 14 September 2023 · filed 14 September 2023
exercised options over 6,421 shares of Edwards Lifesciences (a derivative holding)SEC Form 414 August 2023Employee Stock Option (Right to Acquire) · traded 14 August 2023 · filed 14 August 2023
exercised options over 6,421 shares of Edwards LifesciencesSEC Form 414 August 2023Common Stock · traded 14 August 2023 · filed 14 August 2023
▼ sold on the open market 6,421 shares of Edwards LifesciencesSEC Form 414 August 2023Common Stock · traded 14 August 2023 · filed 14 August 2023
exercised options over 8,660 shares of Edwards Lifesciences (a derivative holding)SEC Form 414 July 2023Employee Stock Option (Right to Acquire) · traded 14 July 2023 · filed 14 July 2023
exercised options over 8,660 shares of Edwards LifesciencesSEC Form 414 July 2023Common Stock · traded 14 July 2023 · filed 14 July 2023
▼ sold on the open market 8,660 shares of Edwards LifesciencesSEC Form 414 July 2023Common Stock · traded 14 July 2023 · filed 14 July 2023
exercised options over 8,660 shares of Edwards Lifesciences (a derivative holding)SEC Form 414 June 2023Employee Stock Option (Right to Acquire) · traded 14 June 2023 · filed 14 June 2023
exercised options over 8,660 shares of Edwards LifesciencesSEC Form 414 June 2023Common Stock · traded 14 June 2023 · filed 14 June 2023
▼ sold on the open market 2,850 shares of Edwards LifesciencesSEC Form 414 June 2023Common Stock · traded 14 June 2023 · filed 14 June 2023
▼ sold on the open market 5,810 shares of Edwards LifesciencesSEC Form 414 June 2023Common Stock · traded 14 June 2023 · filed 14 June 2023
exercised options over 6,421 shares of Edwards Lifesciences (a derivative holding)SEC Form 424 May 2023Employee Stock Option (Right to Acquire) · traded 24 May 2023 · filed 24 May 2023
exercised options over 6,421 shares of Edwards LifesciencesSEC Form 424 May 2023Common Stock · traded 24 May 2023 · filed 24 May 2023
▼ sold on the open market 6,421 shares of Edwards LifesciencesSEC Form 424 May 2023Common Stock · traded 24 May 2023 · filed 24 May 2023
was granted 65,700 shares of Edwards Lifesciences (a derivative holding)SEC Form 415 May 2023Employee Stock Option (Right to Acquire) · traded 11 May 2023 · filed 15 May 2023
was granted 9,725 shares of Edwards Lifesciences (a derivative holding)SEC Form 415 May 2023Performance Rights · traded 11 May 2023 · filed 15 May 2023
was granted 7,775 shares of Edwards LifesciencesSEC Form 415 May 2023Common Stock · traded 11 May 2023 · filed 15 May 2023
exercised options over 5,415 shares of Edwards Lifesciences (a derivative holding)SEC Form 49 May 2023Performance Rights · traded 7 May 2023 · filed 9 May 2023
exercised options over 5,415 shares of Edwards LifesciencesSEC Form 49 May 2023Common Stock · traded 7 May 2023 · filed 9 May 2023
had shares withheld for tax on 2,583 shares of Edwards LifesciencesSEC Form 49 May 2023Common Stock · traded 7 May 2023 · filed 9 May 2023
had shares withheld for tax on 1,472 shares of Edwards LifesciencesSEC Form 49 May 2023Common Stock · traded 8 May 2023 · filed 9 May 2023
had shares withheld for tax on 383 shares of Edwards LifesciencesSEC Form 44 May 2023Common Stock · traded 3 May 2023 · filed 4 May 2023
had shares withheld for tax on 396 shares of Edwards LifesciencesSEC Form 44 May 2023Common Stock · traded 4 May 2023 · filed 4 May 2023
was granted 3,235 shares of Edwards LifesciencesSEC Form 417 February 2023Common Stock · traded 16 February 2023 · filed 17 February 2023
exercised options over 7,236 shares of Edwards Lifesciences (a derivative holding)SEC Form 413 December 2022Employee Stock Option (Right to Acquire) · traded 13 December 2022 · filed 13 December 2022
exercised options over 7,236 shares of Edwards LifesciencesSEC Form 413 December 2022Common Stock · traded 13 December 2022 · filed 13 December 2022
▼ sold on the open market 300 shares of Edwards LifesciencesSEC Form 413 December 2022Common Stock · traded 13 December 2022 · filed 13 December 2022
▼ sold on the open market 6,936 shares of Edwards LifesciencesSEC Form 413 December 2022Common Stock · traded 13 December 2022 · filed 13 December 2022
exercised options over 7,242 shares of Edwards Lifesciences (a derivative holding)SEC Form 48 November 2022Employee Stock Option (Right to Acquire) · traded 8 November 2022 · filed 8 November 2022
exercised options over 7,242 shares of Edwards LifesciencesSEC Form 48 November 2022Common Stock · traded 8 November 2022 · filed 8 November 2022
▼ sold on the open market 7,242 shares of Edwards LifesciencesSEC Form 48 November 2022Common Stock · traded 8 November 2022 · filed 8 November 2022
exercised options over 7,242 shares of Edwards Lifesciences (a derivative holding)SEC Form 411 October 2022Employee Stock Option (Right to Acquire) · traded 11 October 2022 · filed 11 October 2022
exercised options over 7,242 shares of Edwards LifesciencesSEC Form 411 October 2022Common Stock · traded 11 October 2022 · filed 11 October 2022
▼ sold on the open market 7,242 shares of Edwards LifesciencesSEC Form 411 October 2022Common Stock · traded 11 October 2022 · filed 11 October 2022
exercised options over 7,242 shares of Edwards Lifesciences (a derivative holding)SEC Form 46 September 2022Employee Stock Option (Right to Acquire) · traded 6 September 2022 · filed 6 September 2022
exercised options over 7,242 shares of Edwards LifesciencesSEC Form 46 September 2022Common Stock · traded 6 September 2022 · filed 6 September 2022
▼ sold on the open market 7,242 shares of Edwards LifesciencesSEC Form 46 September 2022Common Stock · traded 6 September 2022 · filed 6 September 2022
exercised options over 7,242 shares of Edwards Lifesciences (a derivative holding)SEC Form 49 August 2022Employee Stock Option (Right to Acquire) · traded 9 August 2022 · filed 9 August 2022
exercised options over 7,242 shares of Edwards LifesciencesSEC Form 49 August 2022Common Stock · traded 9 August 2022 · filed 9 August 2022
▼ sold on the open market 1,918 shares of Edwards LifesciencesSEC Form 49 August 2022Common Stock · traded 9 August 2022 · filed 9 August 2022
▼ sold on the open market 5,324 shares of Edwards LifesciencesSEC Form 49 August 2022Common Stock · traded 9 August 2022 · filed 9 August 2022
exercised options over 7,242 shares of Edwards Lifesciences (a derivative holding)SEC Form 45 July 2022Employee Stock Option (Right to Acquire) · traded 5 July 2022 · filed 5 July 2022
exercised options over 7,242 shares of Edwards LifesciencesSEC Form 45 July 2022Common Stock · traded 5 July 2022 · filed 5 July 2022
▼ sold on the open market 7,242 shares of Edwards LifesciencesSEC Form 45 July 2022Common Stock · traded 5 July 2022 · filed 5 July 2022
exercised options over 7,242 shares of Edwards Lifesciences (a derivative holding)SEC Form 41 June 2022Employee Stock Option (Right to Acquire) · traded 1 June 2022 · filed 1 June 2022
exercised options over 7,242 shares of Edwards LifesciencesSEC Form 41 June 2022Common Stock · traded 1 June 2022 · filed 1 June 2022
▼ sold on the open market 2,763 shares of Edwards LifesciencesSEC Form 41 June 2022Common Stock · traded 1 June 2022 · filed 1 June 2022
▼ sold on the open market 4,479 shares of Edwards LifesciencesSEC Form 41 June 2022Common Stock · traded 1 June 2022 · filed 1 June 2022
had shares withheld for tax on 1,816 shares of Edwards LifesciencesSEC Form 417 May 2022Common Stock · traded 17 May 2022 · filed 17 May 2022
exercised options over 13,256 shares of Edwards Lifesciences (a derivative holding)SEC Form 410 May 2022Performance Rights · traded 8 May 2022 · filed 10 May 2022
exercised options over 7,242 shares of Edwards Lifesciences (a derivative holding)SEC Form 410 May 2022Employee Stock Option (Right to Acquire) · traded 10 May 2022 · filed 10 May 2022
had shares withheld for tax on 679 shares of Edwards LifesciencesSEC Form 410 May 2022Common Stock · traded 7 May 2022 · filed 10 May 2022
exercised options over 13,256 shares of Edwards LifesciencesSEC Form 410 May 2022Common Stock · traded 8 May 2022 · filed 10 May 2022
had shares withheld for tax on 8,007 shares of Edwards LifesciencesSEC Form 410 May 2022Common Stock · traded 8 May 2022 · filed 10 May 2022
exercised options over 7,242 shares of Edwards LifesciencesSEC Form 410 May 2022Common Stock · traded 10 May 2022 · filed 10 May 2022
▼ sold on the open market 2,674 shares of Edwards LifesciencesSEC Form 410 May 2022Common Stock · traded 10 May 2022 · filed 10 May 2022
▼ sold on the open market 4,568 shares of Edwards LifesciencesSEC Form 410 May 2022Common Stock · traded 10 May 2022 · filed 10 May 2022
was granted 39,800 shares of Edwards Lifesciences (a derivative holding)SEC Form 45 May 2022Employee Stock Option (Right to Acquire) · traded 3 May 2022 · filed 5 May 2022
was granted 5,550 shares of Edwards Lifesciences (a derivative holding)SEC Form 45 May 2022Performance Rights · traded 3 May 2022 · filed 5 May 2022
was granted 4,425 shares of Edwards LifesciencesSEC Form 45 May 2022Common Stock · traded 3 May 2022 · filed 5 May 2022
had shares withheld for tax on 567 shares of Edwards LifesciencesSEC Form 45 May 2022Common Stock · traded 4 May 2022 · filed 5 May 2022
exercised options over 7,242 shares of Edwards Lifesciences (a derivative holding)SEC Form 45 April 2022Employee Stock Option (Right to Acquire) · traded 5 April 2022 · filed 5 April 2022
exercised options over 7,242 shares of Edwards LifesciencesSEC Form 45 April 2022Common Stock · traded 5 April 2022 · filed 5 April 2022
▼ sold on the open market 400 shares of Edwards LifesciencesSEC Form 45 April 2022Common Stock · traded 5 April 2022 · filed 5 April 2022
▼ sold on the open market 2,975 shares of Edwards LifesciencesSEC Form 45 April 2022Common Stock · traded 5 April 2022 · filed 5 April 2022
▼ sold on the open market 3,867 shares of Edwards LifesciencesSEC Form 45 April 2022Common Stock · traded 5 April 2022 · filed 5 April 2022
exercised options over 7,242 shares of Edwards Lifesciences (a derivative holding)SEC Form 48 March 2022Employee Stock Option (Right to Acquire) · traded 8 March 2022 · filed 8 March 2022
exercised options over 7,242 shares of Edwards LifesciencesSEC Form 48 March 2022Common Stock · traded 8 March 2022 · filed 8 March 2022
▼ sold on the open market 1,695 shares of Edwards LifesciencesSEC Form 48 March 2022Common Stock · traded 8 March 2022 · filed 8 March 2022
▼ sold on the open market 2,000 shares of Edwards LifesciencesSEC Form 48 March 2022Common Stock · traded 8 March 2022 · filed 8 March 2022
▼ sold on the open market 3,547 shares of Edwards LifesciencesSEC Form 48 March 2022Common Stock · traded 8 March 2022 · filed 8 March 2022
exercised options over 4,386 shares of Edwards Lifesciences (a derivative holding)SEC Form 48 February 2022Employee Stock Option (Right to Acquire) · traded 8 February 2022 · filed 8 February 2022
exercised options over 4,386 shares of Edwards LifesciencesSEC Form 48 February 2022Common Stock · traded 8 February 2022 · filed 8 February 2022
▼ sold on the open market 300 shares of Edwards LifesciencesSEC Form 48 February 2022Common Stock · traded 8 February 2022 · filed 8 February 2022
▼ sold on the open market 4,086 shares of Edwards LifesciencesSEC Form 48 February 2022Common Stock · traded 8 February 2022 · filed 8 February 2022
exercised options over 7,830 shares of Edwards Lifesciences (a derivative holding)SEC Form 410 December 2021Employee Stock Option (Right to Acquire) · traded 10 December 2021 · filed 10 December 2021
exercised options over 7,830 shares of Edwards LifesciencesSEC Form 410 December 2021Common Stock · traded 10 December 2021 · filed 10 December 2021
▼ sold on the open market 7,830 shares of Edwards LifesciencesSEC Form 410 December 2021Common Stock · traded 10 December 2021 · filed 10 December 2021
exercised options over 7,830 shares of Edwards Lifesciences (a derivative holding)SEC Form 410 November 2021Employee Stock Option (Right to Acquire) · traded 10 November 2021 · filed 10 November 2021
exercised options over 7,830 shares of Edwards LifesciencesSEC Form 410 November 2021Common Stock · traded 10 November 2021 · filed 10 November 2021
▼ sold on the open market 7,830 shares of Edwards LifesciencesSEC Form 410 November 2021Common Stock · traded 10 November 2021 · filed 10 November 2021
exercised options over 7,830 shares of Edwards Lifesciences (a derivative holding)SEC Form 412 October 2021Employee Stock Option (Right to Acquire) · traded 11 October 2021 · filed 12 October 2021
exercised options over 7,830 shares of Edwards LifesciencesSEC Form 412 October 2021Common Stock · traded 11 October 2021 · filed 12 October 2021
▼ sold on the open market 7,830 shares of Edwards LifesciencesSEC Form 412 October 2021Common Stock · traded 11 October 2021 · filed 12 October 2021
exercised options over 7,830 shares of Edwards Lifesciences (a derivative holding)SEC Form 410 September 2021Employee Stock Option (Right to Acquire) · traded 10 September 2021 · filed 10 September 2021
exercised options over 7,830 shares of Edwards LifesciencesSEC Form 410 September 2021Common Stock · traded 10 September 2021 · filed 10 September 2021
▼ sold on the open market 7,830 shares of Edwards LifesciencesSEC Form 410 September 2021Common Stock · traded 10 September 2021 · filed 10 September 2021
exercised options over 7,830 shares of Edwards LifesciencesSEC Form 410 August 2021Common Stock · traded 10 August 2021 · filed 10 August 2021
▼ sold on the open market 7,830 shares of Edwards LifesciencesSEC Form 410 August 2021Common Stock · traded 10 August 2021 · filed 10 August 2021
exercised options over 7,830 shares of Edwards Lifesciences (a derivative holding)SEC Form 410 August 2021Employee Stock Option (Right to Acquire) · traded 10 August 2021 · filed 10 August 2021
exercised options over 7,830 shares of Edwards LifesciencesSEC Form 412 July 2021Common Stock · traded 12 July 2021 · filed 12 July 2021
▼ sold on the open market 7,830 shares of Edwards LifesciencesSEC Form 412 July 2021Common Stock · traded 12 July 2021 · filed 12 July 2021
exercised options over 7,830 shares of Edwards Lifesciences (a derivative holding)SEC Form 412 July 2021Employee Stock Option (Right to Acquire) · traded 12 July 2021 · filed 12 July 2021
exercised options over 7,830 shares of Edwards LifesciencesSEC Form 414 June 2021Common Stock · traded 14 June 2021 · filed 14 June 2021
▼ sold on the open market 7,830 shares of Edwards LifesciencesSEC Form 414 June 2021Common Stock · traded 14 June 2021 · filed 14 June 2021
exercised options over 7,830 shares of Edwards Lifesciences (a derivative holding)SEC Form 414 June 2021Employee Stock Option (Right to Acquire) · traded 14 June 2021 · filed 14 June 2021
exercised options over 16,406 shares of Edwards LifesciencesSEC Form 419 May 2021Common Stock · traded 17 May 2021 · filed 19 May 2021
had shares withheld for tax on 1,772 shares of Edwards LifesciencesSEC Form 419 May 2021Common Stock · traded 17 May 2021 · filed 19 May 2021
had shares withheld for tax on 8,135 shares of Edwards LifesciencesSEC Form 419 May 2021Common Stock · traded 17 May 2021 · filed 19 May 2021
exercised options over 16,406 shares of Edwards Lifesciences (a derivative holding)SEC Form 419 May 2021Performance Rights · traded 17 May 2021 · filed 19 May 2021
had shares withheld for tax on 2,106 shares of Edwards LifesciencesSEC Form 412 May 2021Common Stock · traded 11 May 2021 · filed 12 May 2021
had shares withheld for tax on 679 shares of Edwards LifesciencesSEC Form 411 May 2021Common Stock · traded 7 May 2021 · filed 11 May 2021
exercised options over 7,830 shares of Edwards LifesciencesSEC Form 411 May 2021Common Stock · traded 10 May 2021 · filed 11 May 2021
▼ sold on the open market 7,830 shares of Edwards LifesciencesSEC Form 411 May 2021Common Stock · traded 10 May 2021 · filed 11 May 2021
exercised options over 7,830 shares of Edwards Lifesciences (a derivative holding)SEC Form 411 May 2021Employee Stock Option (Right to Acquire) · traded 10 May 2021 · filed 11 May 2021
was granted 44,700 shares of Edwards Lifesciences (a derivative holding)SEC Form 46 May 2021Employee Stock Option (Right to Acquire) · traded 4 May 2021 · filed 6 May 2021
was granted 5,700 shares of Edwards Lifesciences (a derivative holding)SEC Form 46 May 2021Performance Rights · traded 4 May 2021 · filed 6 May 2021
was granted 4,575 shares of Edwards LifesciencesSEC Form 46 May 2021Common Stock · traded 4 May 2021 · filed 6 May 2021
exercised options over 7,830 shares of Edwards Lifesciences (a derivative holding)SEC Form 412 April 2021Employee Stock Option (Right to Acquire) · traded 12 April 2021 · filed 12 April 2021
exercised options over 7,830 shares of Edwards LifesciencesSEC Form 412 April 2021Common Stock · traded 12 April 2021 · filed 12 April 2021
▼ sold on the open market 7,830 shares of Edwards LifesciencesSEC Form 412 April 2021Common Stock · traded 12 April 2021 · filed 12 April 2021
exercised options over 7,830 shares of Edwards LifesciencesSEC Form 41 March 2021Common Stock · traded 1 March 2021 · filed 1 March 2021
▼ sold on the open market 7,830 shares of Edwards LifesciencesSEC Form 41 March 2021Common Stock · traded 1 March 2021 · filed 1 March 2021

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.